Here are examples of what you need: - The full name of the patient - The full names and credentials of the professionals handling the patient - The name, address, and type of facility where the injection was administered - The relevant information and indications related to the patient to justify medical necessity - The date and time of administration - Drug information (e.g., drug name, dosage, strength, route of administration, lot number, manufacturer, National Drug Code, etc.) - Relevant assessments that show the patient's osteoporosis, including the location and sizes of fractures (if any) - Provider's order ## **Billing requirements for J3111** Besides the documentation requirements above, please take note of or have the following: - 1 mg = 1 unit - Use the appropriate ICD diagnosis code for your patient - Also use CPT code 96372 since this is a subcutaneous injection - Use either of two modifiers: JW if there's unused medication in a vial (wastage), or JZ if there's no unused medication - Make sure to have prior authorization ## **Other similar codes** - **J3230** - Injection, chlorpromazine hcl, up to 50 mg - **J3240** - Injection, thyrotropin alpha, 0.9 mg, provided in 1.1 mg vial - **J3241** - Injection, teprotumumab-trbw, 10 mg - **J3243** - Injection, tigecycline, 1 mg - **J3244** - Injection, tigecycline (accord), not therapeutically equivalent to J3243, 1 mg Frequently asked questions
We observed knockdown of NRF2 protein and robust growth inhibition upon dox treatment, highlighting the dependency of these cell lines on NRF2 for growth (Fig
was supported by a doctoral fellowship from Ministre de lEnseignement Suprieur et de la Recherche and a fellowship from APREC
Protein kinase and protein phosphatase expression in the central nervous system of G93A mSOD over-expressing mice
A single dose of CJC-1295 increased GH secretion by 2 to 10-fold and IGF-1 levels by 1.5 to 3-fold for up to six days (Teichman, Journal of Clinical Endocrinology & Metabolism )
